Search

everythinglearnresearchcommunity

for

Search:↓

Temporary hair shedding after minoxidil use may indicate effective treatment.

CTP-543 is generally safe for treating alopecia areata.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

3D-ultrasound can non-invasively detect and predict alopecia areata phases and outcomes.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

A new method effectively detects trace sex hormones in cosmetics, ensuring safety.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Fat grafting is safe and effective in both active and stable phases of localized scleroderma.

Neuropathic pain is common in long COVID patients, especially those with depression or severe COVID-19.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

COVID-19 affected Black communities more in Oakland County, MI, but didn't increase death rates.

Researchers found a new gene, hacl-1, that is active in mouse hair follicles during hair growth and may be important for hair biology.

Infrared spectral imaging can map hair growth proteins and sugars without staining.

miR-129-5p affects hair growth by targeting the HOXC13 gene.

Gremlin proteins help regulate hair growth by balancing signals in hair follicles.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

A reliable method was created to measure dutasteride and related molecules in capsules.

Mint water extract boosts protective enzymes in skin cells.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

PAR-1 may play a role in hair growth regulation in human hair follicles.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Baricitinib is effective and safe for treating severe alopecia areata.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Collagenase IV helps control hair growth by affecting certain growth factors.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.